HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients

Introduction. There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. There is evidence that HOMA-adiponectin (HOMA-AD) is more accurate, but its role in HCV patients is unknown. The purpose of this study was to evaluate IR in an HCV sample and contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalczuk, Matheus Truccolo, Kappel, Camila Rippol, Birkhan, Oscar, Bragança, Ana Carolina, Álvares-da-Silva, Mário Reis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405643/
https://www.ncbi.nlm.nih.gov/pubmed/22848841
http://dx.doi.org/10.1155/2012/576584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405643/
https://www.ncbi.nlm.nih.gov/pubmed/22848841
http://dx.doi.org/10.1155/2012/576584

Ejemplares similares